Molecular and clinical study of 18 families with ADCA type II: evidence for genetic heterogeneity and de novo mutation
- PMID: 10330346
- PMCID: PMC1377902
- DOI: 10.1086/302406
Molecular and clinical study of 18 families with ADCA type II: evidence for genetic heterogeneity and de novo mutation
Abstract
The SCA7 mutation has been found in 54 patients and 7 at-risk subjects from 17 families who have autosomal dominant cerebellar ataxia (ADCA) II with progressive pigmentary maculopathy. In one isolated case, haplotype reconstruction through three generations confirmed a de novo mutation owing to paternal meiotic instability. Different disease-associated haplotypes segregated among the SCA7-positive kindreds, which indicated a multiple origin of the mutation. One family with the clinical phenotype of ADCA type II did not have the CAG expansion that indicated locus heterogeneity. The distribution of the repeat size in 944 independent normal chromosomes from controls, unaffected at-risk subjects, and one affected individual fell into two ranges. The majority of the alleles were in the first range of 7-19 CAG repeats. A second range could be identified with 28-35 repeats, and we provide evidence that these repeats represent intermediate alleles that are prone to further expansion. The repeat size of the pathological allele, the widest reported for all CAG-repeat disorders, ranged from 37 to approximately 220. The repeat size showed significant negative correlation with both age at onset and age at death. Analysis of the clinical features in the patients with SCA7 confirmed that the most frequently associated features are pigmentary maculopathy, pyramidal tract involvement, and slow saccades. The subjects with <49 repeats tended to have a less complicated neurological phenotype and a longer disease duration, whereas the converse applied to subjects with >/=49 repeats. The degree of instability during meiotic transmission was greater than in all other CAG-repeat disorders and was particularly striking in paternal transmission, in which a median increase in repeat size of 6 and an interquartile range of 12 were observed, versus a median increase of 3 and interquartile range of 3.5 in maternal transmission.
Similar articles
-
The role of the SCA2 trinucleotide repeat expansion in 89 autosomal dominant cerebellar ataxia families. Frequency, clinical and genetic correlates.Brain. 1998 Mar;121 ( Pt 3):459-67. doi: 10.1093/brain/121.3.459. Brain. 1998. PMID: 9549522
-
Spinocerebellar ataxias in Spanish patients: genetic analysis of familial and sporadic cases. The Ataxia Study Group.Hum Genet. 1999 Jun;104(6):516-22. doi: 10.1007/s004390050997. Hum Genet. 1999. PMID: 10453742
-
Spinocerebellar ataxia type 7 (SCA7) - correlations between phenotype and genotype in one large Belgian family.J Neurol Sci. 1999 Sep 15;168(1):37-46. doi: 10.1016/s0022-510x(99)00176-8. J Neurol Sci. 1999. PMID: 10500272
-
Spinocerebellar ataxia 7 (SCA7).Cytogenet Genome Res. 2003;100(1-4):154-63. doi: 10.1159/000072850. Cytogenet Genome Res. 2003. PMID: 14526176 Review.
-
Spinocerebellar ataxia type 7 associated with pigmentary retinal dystrophy.Eur J Hum Genet. 2004 Jan;12(1):2-15. doi: 10.1038/sj.ejhg.5201108. Eur J Hum Genet. 2004. PMID: 14571264 Review.
Cited by
-
Genetic testing for ataxia in North America.Mol Diagn. 2000 Jun;5(2):91-9. doi: 10.1007/BF03262027. Mol Diagn. 2000. PMID: 11066010
-
Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias.Neurotherapeutics. 2019 Apr;16(2):263-286. doi: 10.1007/s13311-018-00696-y. Neurotherapeutics. 2019. PMID: 30607747 Free PMC article. Review.
-
Autosomal dominant cerebellar ataxia type III: linkage in a large British family to a 7.6-cM region on chromosome 15q14-21.3.Am J Hum Genet. 1999 Aug;65(2):420-6. doi: 10.1086/302495. Am J Hum Genet. 1999. PMID: 10417284 Free PMC article.
-
Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes.Brain. 2014 Sep;137(Pt 9):2444-55. doi: 10.1093/brain/awu174. Epub 2014 Jun 26. Brain. 2014. PMID: 24972706 Free PMC article.
-
Evaluating Glial Fibrillary Acidic Protein and Neurofilament Light as Potential Biomarkers for Spinocerebellar Ataxia 7.Int J Mol Sci. 2025 May 24;26(11):5070. doi: 10.3390/ijms26115070. Int J Mol Sci. 2025. PMID: 40507882 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources